Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 14, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the Society for Immunotherapy of Cancer Conference 2016

Presentation provides immunologic and booster data on GALE-301/GALE-302 SAN RAMON, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company...
November 09, 2016 16:10 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update

GALE-401 expected to initiate a Phase 3 clinical trial in Q2, 2017Top-Line results from NeuVax™ (nelipepimut-S) PRESENT Clinical TrialWebcast and conference call today at 2:00 p.m. P.T. / 5:00 p.m....
November 03, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer

SAN RAMON, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology...
October 31, 2016 16:30 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Reverse Stock Split

1-for-20 Reverse Stock Split Effective November 11, 2016 for Trading November 14, 2016 SAN RAMON, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a...
October 26, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Report Third Quarter 2016 Financial Results and Provide a Corporate Update on Wednesday, November 9, 2016

SAN RAMON, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology...
October 20, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the American College of Surgeons Clinical Congress 2016

SAN RAMON, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology...
October 10, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present NeuVax™ (nelipepimut-S) plus Trastuzumab Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress

SAN RAMON, Calif., Oct. 10, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology...
September 29, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present NeuVax™ (nelipepimut-S) Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress

SAN RAMON, Calif., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and...
September 27, 2016 16:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Presents GALE-301 Folate Binding Protein Expression Data at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

SAN RAMON, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and...
September 20, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Sachs Associates 16th Annual Biotech in Europe Forum

SAN RAMON, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and...